Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Location
Fremont, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 525% % -20%
Quick Ratio 66% % -19%
Debt-to-equity 31% % 19%
Operating Margin -12% % 91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128,550,136 shares 1.5%
Common Stock, Shares, Outstanding 128,550,136 shares -0.51%
Entity Public Float $393,000,000 USD -41%
Common Stock, Value, Issued $129,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 127,745,939 shares -2.2%
Weighted Average Number of Shares Outstanding, Diluted 127,745,939 shares -2.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $201,211,000 USD 813%
Revenue from Contract with Customer, Excluding Assessed Tax $201,493,000 USD 0.52%
Research and Development Expense $36,468,000 USD -7.4%
Selling and Marketing Expense $49,440,000 USD 0.66%
General and Administrative Expense $58,936,000 USD 37%
Operating Income (Loss) $40,384,000 USD -97%
Nonoperating Income (Expense) $10,543,000 USD -29%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $29,841,000 USD -424%
Income Tax Expense (Benefit) $36,698,000 USD 11368%
Net Income (Loss) Attributable to Parent $11,402,000 USD -85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $90,853,000 USD -8%
Accounts Receivable, after Allowance for Credit Loss, Current $62,509,000 USD 3.2%
Inventory, Net $48,428,000 USD 10%
Other Assets, Current $2,977,000 USD 53%
Assets, Current $391,996,000 USD -1.1%
Property, Plant and Equipment, Net $18,009,000 USD 0.26%
Operating Lease, Right-of-Use Asset $11,315,000 USD 11%
Intangible Assets, Net (Excluding Goodwill) $16,821,000 USD -16%
Goodwill $16,697,000 USD 0.2%
Other Assets, Noncurrent $6,704,000 USD 41%
Assets $461,542,000 USD -7.6%
Accrued Liabilities, Current $23,417,000 USD 9.2%
Contract with Customer, Liability, Current $28,504,000 USD 12%
Liabilities, Current $77,804,000 USD 15%
Contract with Customer, Liability, Noncurrent $18,339,000 USD 14%
Operating Lease, Liability, Noncurrent $14,042,000 USD 86%
Other Liabilities, Noncurrent $2,307,000 USD -2.4%
Liabilities $119,803,000 USD 15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,241,000 USD 13906%
Retained Earnings (Accumulated Deficit) $101,738,000 USD -189%
Stockholders' Equity Attributable to Parent $341,739,000 USD -14%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $341,739,000 USD -14%
Liabilities and Equity $461,542,000 USD -7.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $125,000 USD -103%
Net Cash Provided by (Used in) Financing Activities $11,545,000 USD -816%
Net Cash Provided by (Used in) Investing Activities $9,452,000 USD
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 128,550,136 shares -0.51%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,446,000 USD -328%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $90,853,000 USD -8%
Deferred Tax Assets, Valuation Allowance $38,565,000 USD 1277%
Deferred Tax Assets, Gross $41,820,000 USD 7.9%
Operating Lease, Liability $16,922,000 USD 50%
Depreciation $3,900,000 USD 11%
Payments to Acquire Property, Plant, and Equipment $849,000 USD 50%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $64,314,000 USD -1260%
Lessee, Operating Lease, Liability, to be Paid $21,319,000 USD 80%
Property, Plant and Equipment, Gross $30,143,000 USD 13%
Operating Lease, Liability, Current $2,880,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,969,000 USD 37%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,479,000 USD -13%
Operating Lease, Weighted Average Discount Rate, Percent 0.045 pure 32%
Deferred Income Tax Expense (Benefit) $336,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,397,000 USD 687%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,502,000 USD 39%
Deferred Tax Assets, Operating Loss Carryforwards $6,384,000 USD 297%
Unrecognized Tax Benefits $3,528,000 USD -2%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,837,000 USD -11%
Additional Paid in Capital $441,107,000 USD 2.4%
Amortization of Intangible Assets $3,700,000 USD 0%
Depreciation, Depletion and Amortization $1,875,000 USD 10%
Deferred Tax Assets, Net of Valuation Allowance $3,255,000 USD -91%
Share-based Payment Arrangement, Expense $24,585,000 USD -8.4%
Interest Expense $1,839,000 USD -31%